| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 43 | 2023 | 561 | 13.980 |
Why?
|
| Carcinoma, Squamous Cell | 17 | 2021 | 629 | 3.860 |
Why?
|
| Body Image | 7 | 2023 | 100 | 3.700 |
Why?
|
| Free Tissue Flaps | 16 | 2022 | 67 | 3.690 |
Why?
|
| Patient Readmission | 10 | 2018 | 267 | 3.150 |
Why?
|
| Postoperative Complications | 20 | 2022 | 1615 | 2.440 |
Why?
|
| Cancer Survivors | 6 | 2022 | 146 | 2.360 |
Why?
|
| Patient Reported Outcome Measures | 5 | 2021 | 114 | 2.290 |
Why?
|
| Laryngectomy | 7 | 2020 | 30 | 2.240 |
Why?
|
| Laryngeal Neoplasms | 5 | 2020 | 47 | 1.920 |
Why?
|
| Radiotherapy, Adjuvant | 8 | 2021 | 125 | 1.910 |
Why?
|
| Aged | 49 | 2023 | 14862 | 1.540 |
Why?
|
| Middle Aged | 52 | 2023 | 21147 | 1.490 |
Why?
|
| Otolaryngology | 4 | 2020 | 38 | 1.490 |
Why?
|
| Medical Oncology | 2 | 2022 | 110 | 1.480 |
Why?
|
| Retrospective Studies | 40 | 2023 | 7277 | 1.450 |
Why?
|
| Mouth Neoplasms | 8 | 2022 | 206 | 1.390 |
Why?
|
| Body Dysmorphic Disorders | 2 | 2020 | 13 | 1.380 |
Why?
|
| Humans | 93 | 2023 | 68618 | 1.360 |
Why?
|
| Chemoradiotherapy, Adjuvant | 4 | 2021 | 33 | 1.270 |
Why?
|
| Neck Dissection | 10 | 2021 | 55 | 1.230 |
Why?
|
| Otorhinolaryngologic Diseases | 3 | 2020 | 14 | 1.170 |
Why?
|
| Male | 56 | 2023 | 37321 | 1.170 |
Why?
|
| Female | 56 | 2023 | 38074 | 1.160 |
Why?
|
| Quality of Life | 6 | 2023 | 1515 | 1.130 |
Why?
|
| Neck | 6 | 2022 | 62 | 1.110 |
Why?
|
| Medicaid | 5 | 2022 | 302 | 1.100 |
Why?
|
| Health Services Accessibility | 3 | 2022 | 581 | 1.080 |
Why?
|
| Survival Analysis | 9 | 2021 | 714 | 1.080 |
Why?
|
| Databases, Factual | 11 | 2020 | 622 | 1.030 |
Why?
|
| Guideline Adherence | 2 | 2018 | 287 | 1.020 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 143 | 1.020 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 154 | 1.010 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 2 | 2017 | 62 | 1.010 |
Why?
|
| Betacoronavirus | 4 | 2020 | 116 | 1.010 |
Why?
|
| Neoplasm Staging | 13 | 2021 | 800 | 0.970 |
Why?
|
| Head | 3 | 2022 | 59 | 0.950 |
Why?
|
| Time-to-Treatment | 3 | 2020 | 117 | 0.930 |
Why?
|
| Oropharyngeal Neoplasms | 7 | 2019 | 94 | 0.910 |
Why?
|
| Adult | 33 | 2023 | 21403 | 0.900 |
Why?
|
| Aged, 80 and over | 17 | 2023 | 4848 | 0.830 |
Why?
|
| United States | 24 | 2022 | 7367 | 0.810 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 378 | 0.790 |
Why?
|
| Risk Factors | 15 | 2022 | 5731 | 0.780 |
Why?
|
| Proportional Hazards Models | 8 | 2021 | 792 | 0.770 |
Why?
|
| Patient Protection and Affordable Care Act | 3 | 2022 | 59 | 0.760 |
Why?
|
| Survival Rate | 10 | 2021 | 1056 | 0.750 |
Why?
|
| Pain, Procedural | 1 | 2020 | 4 | 0.730 |
Why?
|
| Disease-Free Survival | 7 | 2018 | 349 | 0.710 |
Why?
|
| Acute Pain | 1 | 2020 | 35 | 0.700 |
Why?
|
| Cohort Studies | 12 | 2022 | 2358 | 0.700 |
Why?
|
| Transplant Donor Site | 1 | 2019 | 3 | 0.690 |
Why?
|
| Fibula | 1 | 2019 | 13 | 0.680 |
Why?
|
| Perforator Flap | 1 | 2019 | 10 | 0.680 |
Why?
|
| Patient Education as Topic | 2 | 2022 | 425 | 0.650 |
Why?
|
| Papillomavirus Infections | 5 | 2020 | 194 | 0.650 |
Why?
|
| Combined Modality Therapy | 7 | 2021 | 951 | 0.630 |
Why?
|
| Pain Management | 1 | 2020 | 186 | 0.630 |
Why?
|
| Young Adult | 13 | 2022 | 5717 | 0.620 |
Why?
|
| Osteoradionecrosis | 1 | 2018 | 7 | 0.620 |
Why?
|
| Travel | 1 | 2018 | 38 | 0.620 |
Why?
|
| Registries | 3 | 2018 | 733 | 0.620 |
Why?
|
| Laryngeal Diseases | 1 | 2017 | 22 | 0.600 |
Why?
|
| Microsurgery | 4 | 2022 | 46 | 0.590 |
Why?
|
| Health Services | 1 | 2018 | 87 | 0.590 |
Why?
|
| Treatment Outcome | 18 | 2021 | 7029 | 0.590 |
Why?
|
| Patient Discharge | 2 | 2016 | 294 | 0.580 |
Why?
|
| Multivariate Analysis | 7 | 2021 | 1046 | 0.560 |
Why?
|
| Risk Assessment | 8 | 2021 | 2007 | 0.560 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 378 | 0.540 |
Why?
|
| Mouth | 3 | 2021 | 64 | 0.540 |
Why?
|
| Pilot Projects | 4 | 2023 | 1342 | 0.530 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 136 | 0.520 |
Why?
|
| Hospital Mortality | 2 | 2019 | 384 | 0.520 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 772 | 0.510 |
Why?
|
| Tracheostomy | 3 | 2020 | 31 | 0.510 |
Why?
|
| Prognosis | 10 | 2021 | 2093 | 0.500 |
Why?
|
| Telemedicine | 2 | 2020 | 700 | 0.500 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 177 | 0.490 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2014 | 9 | 0.490 |
Why?
|
| Time Factors | 8 | 2021 | 4655 | 0.480 |
Why?
|
| Internship and Residency | 2 | 2020 | 596 | 0.480 |
Why?
|
| Airway Extubation | 1 | 2014 | 17 | 0.480 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2014 | 24 | 0.480 |
Why?
|
| Insurance Coverage | 5 | 2022 | 99 | 0.470 |
Why?
|
| Chemoradiotherapy | 1 | 2014 | 54 | 0.470 |
Why?
|
| Surgical Flaps | 5 | 2021 | 120 | 0.460 |
Why?
|
| Leukoplakia, Hairy | 1 | 2013 | 2 | 0.450 |
Why?
|
| HIV Seronegativity | 1 | 2013 | 11 | 0.450 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 190 | 0.450 |
Why?
|
| Adolescent | 10 | 2021 | 8912 | 0.450 |
Why?
|
| Parotid Neoplasms | 3 | 2019 | 49 | 0.440 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 55 | 0.440 |
Why?
|
| Ear | 1 | 2013 | 12 | 0.430 |
Why?
|
| Salvage Therapy | 3 | 2019 | 82 | 0.430 |
Why?
|
| Otologic Surgical Procedures | 1 | 2013 | 23 | 0.430 |
Why?
|
| Margins of Excision | 3 | 2021 | 15 | 0.430 |
Why?
|
| Incus | 1 | 2011 | 3 | 0.400 |
Why?
|
| Logistic Models | 4 | 2017 | 1420 | 0.400 |
Why?
|
| Ear Ossicles | 1 | 2011 | 2 | 0.400 |
Why?
|
| Laryngoplasty | 1 | 2011 | 8 | 0.400 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2011 | 7 | 0.400 |
Why?
|
| Vocal Cord Paralysis | 1 | 2011 | 18 | 0.390 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2021 | 446 | 0.390 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2011 | 37 | 0.380 |
Why?
|
| Pandemics | 5 | 2020 | 352 | 0.380 |
Why?
|
| Suicide | 2 | 2022 | 116 | 0.370 |
Why?
|
| Health Priorities | 2 | 2021 | 23 | 0.370 |
Why?
|
| Insurance, Health | 4 | 2022 | 201 | 0.360 |
Why?
|
| Survivors | 2 | 2023 | 256 | 0.350 |
Why?
|
| Comorbidity | 5 | 2020 | 1426 | 0.340 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 514 | 0.340 |
Why?
|
| Bone Transplantation | 2 | 2020 | 43 | 0.330 |
Why?
|
| Triage | 2 | 2020 | 109 | 0.330 |
Why?
|
| Health Services Needs and Demand | 2 | 2021 | 149 | 0.330 |
Why?
|
| Self Report | 2 | 2021 | 371 | 0.330 |
Why?
|
| Carcinoma, Acinar Cell | 2 | 2019 | 14 | 0.330 |
Why?
|
| Needs Assessment | 2 | 2021 | 186 | 0.320 |
Why?
|
| Carcinoma, Mucoepidermoid | 2 | 2019 | 14 | 0.320 |
Why?
|
| Prospective Studies | 4 | 2020 | 3705 | 0.310 |
Why?
|
| History, 18th Century | 3 | 2013 | 26 | 0.310 |
Why?
|
| Cutaneous Fistula | 2 | 2020 | 11 | 0.310 |
Why?
|
| Postoperative Care | 2 | 2020 | 163 | 0.300 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 955 | 0.300 |
Why?
|
| Referral and Consultation | 2 | 2021 | 383 | 0.290 |
Why?
|
| Tongue Neoplasms | 2 | 2019 | 29 | 0.280 |
Why?
|
| Counseling | 2 | 2020 | 280 | 0.280 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2013 | 756 | 0.280 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 536 | 0.270 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 3259 | 0.260 |
Why?
|
| Length of Stay | 2 | 2021 | 780 | 0.260 |
Why?
|
| Pharynx | 2 | 2017 | 89 | 0.260 |
Why?
|
| Quality of Health Care | 2 | 2018 | 322 | 0.240 |
Why?
|
| Attitude of Health Personnel | 2 | 2022 | 442 | 0.240 |
Why?
|
| Deglutition Disorders | 2 | 2018 | 297 | 0.240 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2022 | 87 | 0.240 |
Why?
|
| Surgical Wound Infection | 2 | 2022 | 168 | 0.230 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 445 | 0.210 |
Why?
|
| Survivorship | 2 | 2022 | 20 | 0.210 |
Why?
|
| Medicare | 3 | 2022 | 319 | 0.210 |
Why?
|
| South Carolina | 2 | 2019 | 2752 | 0.200 |
Why?
|
| History, 17th Century | 2 | 2011 | 17 | 0.200 |
Why?
|
| Urban Health | 1 | 2021 | 49 | 0.200 |
Why?
|
| History, 19th Century | 2 | 2011 | 95 | 0.190 |
Why?
|
| Rural Health | 1 | 2021 | 66 | 0.190 |
Why?
|
| Oral Surgical Procedures | 1 | 2021 | 15 | 0.190 |
Why?
|
| Jugular Veins | 1 | 2021 | 37 | 0.190 |
Why?
|
| Thigh | 2 | 2018 | 27 | 0.190 |
Why?
|
| Databases as Topic | 1 | 2021 | 49 | 0.190 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2021 | 40 | 0.190 |
Why?
|
| Neoplasms | 2 | 2023 | 1667 | 0.190 |
Why?
|
| Mandibular Reconstruction | 1 | 2020 | 1 | 0.190 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2279 | 0.190 |
Why?
|
| Unemployment | 1 | 2020 | 18 | 0.180 |
Why?
|
| Pharyngeal Diseases | 1 | 2020 | 21 | 0.180 |
Why?
|
| Otolaryngologists | 1 | 2020 | 5 | 0.180 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 25 | 0.180 |
Why?
|
| Nomograms | 1 | 2020 | 19 | 0.180 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 44 | 0.180 |
Why?
|
| Bone Plates | 1 | 2020 | 49 | 0.180 |
Why?
|
| Linear Models | 1 | 2021 | 521 | 0.180 |
Why?
|
| Health Resources | 1 | 2020 | 76 | 0.180 |
Why?
|
| Risk Adjustment | 1 | 2020 | 49 | 0.180 |
Why?
|
| Residence Characteristics | 1 | 2021 | 252 | 0.170 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 201 | 0.170 |
Why?
|
| Dexamethasone | 1 | 2020 | 150 | 0.170 |
Why?
|
| Physician-Patient Relations | 1 | 2022 | 261 | 0.170 |
Why?
|
| Infection Control | 1 | 2020 | 101 | 0.170 |
Why?
|
| Perioperative Care | 1 | 2020 | 100 | 0.170 |
Why?
|
| Vascularized Composite Allotransplantation | 1 | 2019 | 17 | 0.170 |
Why?
|
| Papillomavirus Vaccines | 1 | 2020 | 93 | 0.170 |
Why?
|
| Frailty | 1 | 2019 | 34 | 0.170 |
Why?
|
| Incidence | 3 | 2022 | 1603 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 369 | 0.160 |
Why?
|
| Social Isolation | 1 | 2019 | 40 | 0.160 |
Why?
|
| Cognition | 1 | 2023 | 513 | 0.160 |
Why?
|
| Myocutaneous Flap | 1 | 2018 | 6 | 0.160 |
Why?
|
| Data Collection | 1 | 2020 | 420 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 248 | 0.160 |
Why?
|
| Melanoma | 1 | 2022 | 335 | 0.160 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2018 | 33 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 332 | 0.160 |
Why?
|
| Osteotomy | 1 | 2018 | 46 | 0.160 |
Why?
|
| Tumor Virus Infections | 2 | 2016 | 32 | 0.150 |
Why?
|
| Fistula | 1 | 2018 | 29 | 0.150 |
Why?
|
| Speech Disorders | 1 | 2017 | 7 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2020 | 652 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 106 | 0.150 |
Why?
|
| Depression | 3 | 2020 | 943 | 0.150 |
Why?
|
| Pamphlets | 1 | 2017 | 27 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2018 | 880 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 375 | 0.150 |
Why?
|
| Program Evaluation | 1 | 2020 | 502 | 0.150 |
Why?
|
| Papillomaviridae | 2 | 2018 | 104 | 0.150 |
Why?
|
| Femur | 1 | 2018 | 113 | 0.150 |
Why?
|
| Language Disorders | 1 | 2017 | 22 | 0.150 |
Why?
|
| Gastrostomy | 1 | 2018 | 110 | 0.150 |
Why?
|
| Psychometrics | 1 | 2020 | 514 | 0.150 |
Why?
|
| Chordoma | 1 | 2017 | 9 | 0.150 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2017 | 49 | 0.150 |
Why?
|
| Propensity Score | 1 | 2017 | 117 | 0.150 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2017 | 8 | 0.140 |
Why?
|
| Washington | 1 | 2016 | 27 | 0.140 |
Why?
|
| Patient Selection | 1 | 2020 | 592 | 0.140 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 447 | 0.140 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 91 | 0.140 |
Why?
|
| Models, Anatomic | 2 | 2018 | 51 | 0.140 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 274 | 0.140 |
Why?
|
| Sex Factors | 2 | 2020 | 1266 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1465 | 0.130 |
Why?
|
| California | 1 | 2016 | 99 | 0.130 |
Why?
|
| Educational Status | 1 | 2017 | 273 | 0.130 |
Why?
|
| Wound Closure Techniques | 1 | 2015 | 3 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2017 | 275 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 468 | 0.130 |
Why?
|
| Caregivers | 1 | 2019 | 365 | 0.130 |
Why?
|
| Chyle | 1 | 2014 | 4 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 498 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2016 | 170 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 281 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2016 | 311 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2018 | 867 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1040 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2014 | 216 | 0.120 |
Why?
|
| Intubation, Intratracheal | 1 | 2014 | 99 | 0.120 |
Why?
|
| Government Regulation | 1 | 2014 | 46 | 0.120 |
Why?
|
| Collagen | 1 | 2017 | 636 | 0.110 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 36 | 0.110 |
Why?
|
| Tracheotomy | 1 | 2013 | 17 | 0.110 |
Why?
|
| Biomedical Research | 2 | 2014 | 310 | 0.110 |
Why?
|
| Skilled Nursing Facilities | 1 | 2013 | 30 | 0.110 |
Why?
|
| Cuba | 1 | 2013 | 8 | 0.110 |
Why?
|
| Spain | 1 | 2013 | 34 | 0.110 |
Why?
|
| Hospitals, University | 1 | 2013 | 169 | 0.110 |
Why?
|
| United Kingdom | 1 | 2013 | 152 | 0.110 |
Why?
|
| Warfare | 1 | 2013 | 58 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 159 | 0.100 |
Why?
|
| Esophagectomy | 1 | 2011 | 26 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2013 | 175 | 0.100 |
Why?
|
| Injections | 1 | 2011 | 119 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2022 | 62 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1864 | 0.100 |
Why?
|
| Pneumonectomy | 1 | 2011 | 79 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 248 | 0.090 |
Why?
|
| Neoplasm Grading | 2 | 2021 | 111 | 0.090 |
Why?
|
| SEER Program | 2 | 2021 | 153 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 711 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 2800 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2013 | 703 | 0.080 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 696 | 0.070 |
Why?
|
| Nuclear Respiratory Factors | 1 | 2006 | 1 | 0.070 |
Why?
|
| Deglutition | 2 | 2019 | 221 | 0.070 |
Why?
|
| Electron Transport Complex IV | 1 | 2006 | 33 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 282 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2006 | 222 | 0.060 |
Why?
|
| Research Design | 2 | 2020 | 729 | 0.050 |
Why?
|
| Antisepsis | 1 | 2022 | 2 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2023 | 193 | 0.050 |
Why?
|
| CTLA-4 Antigen | 1 | 2022 | 45 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1664 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 104 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2021 | 104 | 0.050 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 66 | 0.050 |
Why?
|
| Pharyngectomy | 1 | 2020 | 3 | 0.050 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 18 | 0.050 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 438 | 0.050 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 27 | 0.050 |
Why?
|
| International Cooperation | 1 | 2020 | 88 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2022 | 369 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 307 | 0.040 |
Why?
|
| Feeding Methods | 1 | 2019 | 17 | 0.040 |
Why?
|
| Composite Tissue Allografts | 1 | 2019 | 8 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 211 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 109 | 0.040 |
Why?
|
| Glossectomy | 1 | 2019 | 9 | 0.040 |
Why?
|
| Surgeons | 1 | 2020 | 68 | 0.040 |
Why?
|
| Burnout, Professional | 1 | 2020 | 64 | 0.040 |
Why?
|
| Bone Nails | 1 | 2018 | 32 | 0.040 |
Why?
|
| Cross Infection | 1 | 2020 | 195 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2018 | 242 | 0.040 |
Why?
|
| Femoral Fractures | 1 | 2018 | 45 | 0.040 |
Why?
|
| Bone Screws | 1 | 2018 | 90 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 756 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 368 | 0.040 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 157 | 0.040 |
Why?
|
| Anxiety | 1 | 2020 | 422 | 0.040 |
Why?
|
| Child | 2 | 2018 | 6405 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 32 | 0.030 |
Why?
|
| Parotid Gland | 1 | 2016 | 33 | 0.030 |
Why?
|
| Diet | 1 | 2019 | 514 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 62 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2016 | 99 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2077 | 0.030 |
Why?
|
| Carcinoma | 1 | 2016 | 215 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 1196 | 0.030 |
Why?
|
| Ethical Review | 1 | 2014 | 2 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 1026 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 1753 | 0.030 |
Why?
|
| Human Experimentation | 1 | 2014 | 19 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 540 | 0.030 |
Why?
|
| Ethics Committees, Research | 1 | 2014 | 22 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2020 | 824 | 0.030 |
Why?
|
| Informed Consent | 1 | 2014 | 127 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2012 | 219 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 2891 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1553 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 3187 | 0.020 |
Why?
|
| Education, Medical | 1 | 2013 | 147 | 0.020 |
Why?
|
| Decision Making | 1 | 2013 | 410 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 2223 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2006 | 26 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 65 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2006 | 137 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2006 | 312 | 0.020 |
Why?
|
| RNA Interference | 1 | 2006 | 266 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 396 | 0.020 |
Why?
|
| Binding Sites | 1 | 2006 | 631 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 447 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 434 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 562 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 615 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1027 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 415 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2673 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 881 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 5300 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 8474 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 20881 | 0.000 |
Why?
|